D-0312-2024 Class III Ongoing

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0312-2024 was initiated by Dr. Reddy's Laboratories, Inc. on Jan 18, 2024 and is designated Class III. Reason for recall: Misprint on tablet The recall status is ongoing. Affected quantity: 59,336 bottles.

Recall Details

Product Type
Drugs
Report Date
Feb 14, 2024
Initiation Date
Jan 18, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
59,336 bottles

Product Description

Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-01

Reason for Recall

Misprint on tablet

Distribution Pattern

Nationwide

Code Information

Lot: T2303622; Exp. 06/2026 Lot: T2303626; Exp. 06/2026 Lot: T2303627; Exp. 06/2026 Lot: T2303628; Exp. 06/2026 Lot: T2303629; Exp. 06/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0312-2024
openFDA file date
Oct 26, 2026
Loaded by RegDataLab
Oct 27, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.